Late profound muscle weakness following heart transplantation due to danon disease

被引:31
作者
Van der Starre, Pieter [1 ]
Deuse, Tobias [3 ]
Pritts, Chad [1 ]
Brun, Carlos [1 ]
Vogel, Hannes [2 ]
Oyer, Philip [3 ]
机构
[1] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Neuropathol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA
关键词
genetics; heart transplantation; histology; intensive care; polyneuromyopathy; ACQUIRED WEAKNESS; CARDIOMYOPATHY;
D O I
10.1002/mus.23517
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Postoperative muscle weakness is a serious complication in surgical intensive care patients. It is mostly described as critical illness polyneuromyopathy. Risk factors include intensive care length of stay, sepsis, poor glycemic control, and combined use of corticosteroids and neuromuscular blocking agents, malnutrition, and electrolyte imbalance. Methods: We report a case of late-progressive, profound weakness after heart transplantation for noncompaction cardiomyopathy which required prolonged mechanical ventilation. The patient's muscle strength recovered completely after prolonged rehabilitation. Results: Electromyographic assessment showed myopathy. Muscle biopsy revealed Danon disease, a genetic disorder affecting the lysosomal-associated membrane protein 2 gene (LAMP2). Conclusions: The finding of this genetic disorder was unexpected, because the preoperative echocardiographic diagnosis of noncompaction cardiomyopathy has not been reported in Danon disease. This report underlines the need for early availability of pathology results from the explanted heart, which showed the same disorder. Muscle Nerve, 2013
引用
收藏
页码:135 / 137
页数:3
相关论文
共 8 条
[1]   Danon disease with typical early-onset cardiomyopathy in a male: Focus on a novel LAMP-2 mutation [J].
Bui, Yen K. ;
Renella, Pierangelo ;
Martinez-Agosto, Julian A. ;
Verity, Anthony ;
Madikians, Andranik ;
Alejos, Juan C. .
PEDIATRIC TRANSPLANTATION, 2008, 12 (02) :246-250
[2]   LYSOSOMAL GLYCOGEN-STORAGE DISEASE WITH NORMAL ACID MALTASE [J].
DANON, MJ ;
OH, SJ ;
DIMAURO, S ;
MANALIGOD, JR ;
EASTWOOD, A ;
NAIDU, S ;
SCHLISELFELD, LH .
NEUROLOGY, 1981, 31 (01) :51-57
[3]   Intensive care unit-acquired weakness [J].
Griffiths, Richard D. ;
Hall, Jesse B. .
CRITICAL CARE MEDICINE, 2010, 38 (03) :779-788
[4]   Neurologic complications after solid organ transplantation [J].
Marco, Senzolo ;
Cecilia, Ferronato ;
Patrizia, Burra .
TRANSPLANT INTERNATIONAL, 2009, 22 (03) :269-278
[5]   Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy [J].
Maron, Barry J. ;
Roberts, William C. ;
Arad, Michael ;
Haas, Tammy S. ;
Spirito, Paolo ;
Wright, Gregory B. ;
Almquist, Adrian K. ;
Baffa, Jeanne M. ;
Saul, J. Philip ;
Ho, Carolyn Y. ;
Seidman, Jonathan ;
Seidman, Christine E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (12) :1253-1259
[6]   Molecular and cellular basis of lysosomal transmembrane protein dysfunction [J].
Ruivo, Raquel ;
Anne, Christine ;
Sagne, Corinne ;
Gasnier, Bruno .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04) :636-649
[7]   ICU-acquired weakness [J].
Schweickert, William D. ;
Hall, Jesse .
CHEST, 2007, 131 (05) :1541-1549
[8]   Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology [J].
Zaragoza, Michael V. ;
Arbustini, Eloisa ;
Narula, Jagat .
CURRENT OPINION IN PEDIATRICS, 2007, 19 (06) :619-627